Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS South East London Integrated Care Board
QKK
160 Tooley Street
London
SE1 2TZ
UK
E-mail: hub.queries@nhs.net
NUTS: UKI45
Internet address(es)
Main address: https://www.selondonics.org/icb/
Address of the buyer profile: https://www.selondonics.org/icb/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
SEL ICB Lambeth Community Denosumab Service
II.1.2) Main CPV code
85141000
II.1.3) Type of contract
Services
II.1.4) Short description
Provision of a community-based shared care service for the administration and monitoring of denosumab 60mg/ml for osteoporosis. The service will support patients in Lambeth (or registered with a Lambeth GP) who have been identified by secondary care as clinically appropriate for treatment in the community. The Provider will deliver blood monitoring, prescribing support, and timely administration of injections in accordance with the South East London Shared Care Agreement, while clinical responsibility remains with secondary care.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
49 140.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
85141000
II.2.3) Place of performance
NUTS code:
UKI45
Main site or place of performance:
Community-based healthcare settings within Lambeth; patients registered with Lambeth GP practices or resident in Lambeth.
II.2.4) Description of the procurement
This notice relates to the Lambeth Community Denosumab Service and is an intention to award a contract to the existing provider via Direct Award Process C.
The service provides a community-based shared care pathway for patients prescribed denosumab 60mg/ml for the treatment of osteoporosis. Patients remain under the clinical responsibility of secondary care within South East London, in accordance with the South East London Shared Care Agreement for Denosumab. Secondary care will identify and refer a cohort of clinically appropriate patients for management in the community setting. The Provider will be responsible for delivering the community service, including required blood monitoring, prescribing support, and administration of denosumab injections at clinically appropriate intervals. The service is available to patients referred by secondary care who are registered with a GP in Lambeth or are Lambeth residents and who meet the eligibility criteria set out in the contract and Shared Care Agreement.
The estimated contract value is £49,140 per annum. The contract duration is 6 months from 01/06/2026 to 30/11/2026, with an option to extend for a further 6 months at the discretion of the Authority, up to 31/05/2027.
This is a direct award with no competition under the Provider Selection Regime (PSR) - Direct Award Process C. As such, no award criteria were applied.
The contracting authority has determined that the existing provider will be awarded the contract on the basis that:
The current provider is delivering the service to a satisfactory standard. There are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort
The provider continues to meet all relevant clinical, quality, and service requirements. The decision is made in accordance with PSR requirements for Direct Award Process C.
II.2.5) Award criteria
Cost criterion: Award Criteria: Cost & Quality criteria Cost & Quality criterion: the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard Weighting: 100%
/ Weighting: 100%
II.2.11) Information about options
Options:
Yes
Description of options:
The Contracting Authority may, at its discretion, may extend the contract for a further period of up to 6 months.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
Procurement Route
This contract is intended to be awarded under the Provider Selection Regime (PSR) - Direct Award Process C.
Rationale for Direct Award
The current provider is delivering the service to a satisfactory standard, and there are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort.
The provider continues to meet all relevant clinical, quality, and service requirements.
Decision
The Contracting Authority intends to award the contract to the existing provider in accordance with PSR Direct Award Process C.
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
No tenders or no suitable tenders/requests to participate in response to open procedure
Explanation
Justification: Award of a contract without prior publication of a call for competition in the cases listed below
Reason: The procurement falls outside the scope of application of the regulations
Explanation: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by Tuesday 12th May 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
22/04/2026
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Lambeth Healthcare Ltd
CQC
Akerman Health Centre, Second Floor, 60 Patmos Road
London
SW9 6AF
UK
E-mail: hub.queries@nhs.net
NUTS: UKI
Internet address(es)
URL: https://www.selondonics.org/icb/
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 49 140.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Tuesday 12th May 2026.
This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Written representations should be sent to: hub.psrrepresentation@nhs.net
Award Decision makers: Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care
There was no conflict of interest identified in the decision-making process.
Evaluation Criteria and Weighting
Scoring from 0-4, with percentage allocation based on the importance of the criteria in the service requirement. Key criteria:
Quality and Innovation: 20%
Value for Money: 25%
Integration, Collaboration and Service Sustainability: 20%
Improving Access, Reducing Health Inequalities and Facilitating Choice: 25%
Social Value: 10%
The criteria were applied with their respective weightings as specified, with scoring against a number of sub-categories for each criterion. An assessment against current and future performance for these individual sub-categories was undertaken, resulting in a combined overall score out of 100%.
The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026.
Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net
and must be made to the decision makers within this period.
The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed.
This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (PSR).
No conflicts of interest were identified in the decision-making process.
Decision Makers and Dates of Decision
The decision to proceed with the intention to award was made by:
Andrew Eyres- Corporate Director, Integrated Health and Adult Social Care
Lambeth Together Planning and Finance Group - 23 March 2026
Lambeth Together Senior Management Team - 31 March 2026
Rationale for Selection of Current Provider
The current provider has demonstrated sustained high-quality performance and value for money, including:
Maintaining 100% performance across key service standards, including:
-Provision of service to all appropriately referred patients
-Contacting patients within 72 hours of referral from secondary care
-Issuing patient reminder cards and information leaflets
-Providing consistent feedback from service users and referring acute trusts
-Reporting 0% near misses or incidents from both the provider and acute trust
-Effective financial management, remaining within the agreed budget
-Delivery in line with NICE TA204 (Denosumab for the prevention of osteoporotic fractures in postmenopausal women)
-Alignment with the South East London Osteoporosis Pathway and the South East London Shared Care Agreement for Denosumab 60mg/ml
-Supporting care closer to home and improved patient experience through community-based administration of treatment
-Sustained achievement of ≥95% across key performance indicators, including:
-Timely patient contact within 72 hours
-Provision of patient information materials
-Service user and referrer feedback mechanisms
-Incident reporting compliance
-Annual patient satisfaction feedback demonstrating good service experience
VI.4) Procedures for review
VI.4.1) Review body
NHS South East London Integrated Care Board
160 Tooley Street,
London
SE1 2TZ
UK
E-mail: hub.queries@nhs.net
Internet address(es)
URL: https://www.selondonics.org/icb/
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
The publication of this notice marks the start of the standstill period, commencing on Wednesday 30th April 2026 ending at 23:59 on Tuesday 12 May 2026.
Representations by providers must be submitted by 23:59 on Tuesday 12 May 2026 to: hub.psrrepresentation@nhs.net
and must be made to the decision makers within this period.
The contract may be formally awarded on Wednesday 13 May 2026, provided no representations are received, or once any representations have been addressed..
VI.5) Date of dispatch of this notice
28/04/2026